A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer

Angela Grassi, Lisa Perilli, Laura Albertoni, Sofia Tessarollo, Claudia Mescoli, Emanuele D.L. Urso, Matteo Fassan, Massimo Rugge, Paola Zanovello

Research output: Contribution to journalLetter

3 Citations (Scopus)

Abstract

Up to 20% of colorectal cancer (CRC) node-negative patients develop loco-regional or distant recurrences within 5 years from surgery. No predictive biomarker able to identify the node-negative subjects at high risk of relapse after curative treatment is presently available. Forty-eight localized (i.e. stage I-II) colon cancer patients who underwent radical tumor resection were considered. The expression of five miRNAs, involved in CRC progression, was investigated by qRT-PCR in both tumor tissue and matched normal colon mucosa. Interestingly, we found that the coordinate deregulation of four miRNAs (i.e. miR-18a, miR-21, miR-182 and miR-183), evaluated in the normal mucosa adjacent to tumor, is predictive of relapse within 55months from curative surgery. Our results, if confirmed in independent studies, may help to identify high-risk patients who could benefit most from adjuvant therapy. Moreover, this work highlights the importance of extending the search for tissue biomarkers also to the tumor-adjacent mucosa.

Original languageEnglish
Article number17
JournalMolecular Cancer
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 31 2018

Fingerprint

MicroRNAs
Colonic Neoplasms
Mucous Membrane
Recurrence
Colorectal Neoplasms
Neoplasms
Biomarkers
Colon
Polymerase Chain Reaction
Therapeutics

Keywords

  • Adjacent mucosa
  • Localized colon cancer
  • MicroRNAs
  • Predictive markers
  • Relapse

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Cite this

A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer. / Grassi, Angela; Perilli, Lisa; Albertoni, Laura; Tessarollo, Sofia; Mescoli, Claudia; Urso, Emanuele D.L.; Fassan, Matteo; Rugge, Massimo; Zanovello, Paola.

In: Molecular Cancer, Vol. 17, No. 1, 17, 31.01.2018.

Research output: Contribution to journalLetter

@article{3594ca52e3d34347be4d8091dbbf03d1,
title = "A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer",
abstract = "Up to 20{\%} of colorectal cancer (CRC) node-negative patients develop loco-regional or distant recurrences within 5 years from surgery. No predictive biomarker able to identify the node-negative subjects at high risk of relapse after curative treatment is presently available. Forty-eight localized (i.e. stage I-II) colon cancer patients who underwent radical tumor resection were considered. The expression of five miRNAs, involved in CRC progression, was investigated by qRT-PCR in both tumor tissue and matched normal colon mucosa. Interestingly, we found that the coordinate deregulation of four miRNAs (i.e. miR-18a, miR-21, miR-182 and miR-183), evaluated in the normal mucosa adjacent to tumor, is predictive of relapse within 55months from curative surgery. Our results, if confirmed in independent studies, may help to identify high-risk patients who could benefit most from adjuvant therapy. Moreover, this work highlights the importance of extending the search for tissue biomarkers also to the tumor-adjacent mucosa.",
keywords = "Adjacent mucosa, Localized colon cancer, MicroRNAs, Predictive markers, Relapse",
author = "Angela Grassi and Lisa Perilli and Laura Albertoni and Sofia Tessarollo and Claudia Mescoli and Urso, {Emanuele D.L.} and Matteo Fassan and Massimo Rugge and Paola Zanovello",
year = "2018",
month = "1",
day = "31",
doi = "10.1186/s12943-018-0770-8",
language = "English",
volume = "17",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer

AU - Grassi, Angela

AU - Perilli, Lisa

AU - Albertoni, Laura

AU - Tessarollo, Sofia

AU - Mescoli, Claudia

AU - Urso, Emanuele D.L.

AU - Fassan, Matteo

AU - Rugge, Massimo

AU - Zanovello, Paola

PY - 2018/1/31

Y1 - 2018/1/31

N2 - Up to 20% of colorectal cancer (CRC) node-negative patients develop loco-regional or distant recurrences within 5 years from surgery. No predictive biomarker able to identify the node-negative subjects at high risk of relapse after curative treatment is presently available. Forty-eight localized (i.e. stage I-II) colon cancer patients who underwent radical tumor resection were considered. The expression of five miRNAs, involved in CRC progression, was investigated by qRT-PCR in both tumor tissue and matched normal colon mucosa. Interestingly, we found that the coordinate deregulation of four miRNAs (i.e. miR-18a, miR-21, miR-182 and miR-183), evaluated in the normal mucosa adjacent to tumor, is predictive of relapse within 55months from curative surgery. Our results, if confirmed in independent studies, may help to identify high-risk patients who could benefit most from adjuvant therapy. Moreover, this work highlights the importance of extending the search for tissue biomarkers also to the tumor-adjacent mucosa.

AB - Up to 20% of colorectal cancer (CRC) node-negative patients develop loco-regional or distant recurrences within 5 years from surgery. No predictive biomarker able to identify the node-negative subjects at high risk of relapse after curative treatment is presently available. Forty-eight localized (i.e. stage I-II) colon cancer patients who underwent radical tumor resection were considered. The expression of five miRNAs, involved in CRC progression, was investigated by qRT-PCR in both tumor tissue and matched normal colon mucosa. Interestingly, we found that the coordinate deregulation of four miRNAs (i.e. miR-18a, miR-21, miR-182 and miR-183), evaluated in the normal mucosa adjacent to tumor, is predictive of relapse within 55months from curative surgery. Our results, if confirmed in independent studies, may help to identify high-risk patients who could benefit most from adjuvant therapy. Moreover, this work highlights the importance of extending the search for tissue biomarkers also to the tumor-adjacent mucosa.

KW - Adjacent mucosa

KW - Localized colon cancer

KW - MicroRNAs

KW - Predictive markers

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=85041480572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041480572&partnerID=8YFLogxK

U2 - 10.1186/s12943-018-0770-8

DO - 10.1186/s12943-018-0770-8

M3 - Letter

C2 - 29386021

AN - SCOPUS:85041480572

VL - 17

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

IS - 1

M1 - 17

ER -